Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 28;11(19):5750.
doi: 10.3390/jcm11195750.

Face Transplant: Indications, Outcomes, and Ethical Issues-Where Do We Stand?

Affiliations
Review

Face Transplant: Indications, Outcomes, and Ethical Issues-Where Do We Stand?

Simone La Padula et al. J Clin Med. .

Abstract

Background: The addition of face allotransplantation (FT) to the head and neck reconstructive surgery arsenal has started a true revolution. This study is aimed at providing an extensive analysis of the current practice of composite tissue allotransplantation. Moreover, a thorough description of pre-procedural, intra-operative, and post-procedural settings, indications, contraindications, outcomes, ethical considerations, and future perspectives is provided. Methods: The authors’ experience was supplemented with a literature review performed by using the PubMed, MEDLINE, and Embase databases on 21 February 2022. The search terms used were “face transplantation indications”, “face transplantation complications”, and “face transplantation ethical issues”. Results: The most recent achievements and long-term clinical sequelae of FT are classified and summarized. A large number of records (4435) were identified. Seventy-five articles were assessed for eligibility. Publications without new data and reports with a patient follow-up < 5 years were excluded. Nineteen articles met the criteria for inclusion. Conclusions: The most recent achievements in the field of FT may be combined with cutting-edge regenerative medicine procedures and innovative immunological processing. It is paramount to build strong international networks between the world FT experts in order to achieve higher-level outcomes and reduce the complication rate. Nevertheless, the utmost caution is required in patient selection, clinical assessment, strict follow-up, and rejection management.

Keywords: chronic rejection; decellularization; ethics; face transplantation; face transplantation outcomes; facial allotransplantation; facial disfigurement; regenerative medicine; vascularized composite tissue allotransplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
This diagram shows the flow of information through the different phases of this review.
Figure 2
Figure 2
Facial tissue defect classification system schematized by the authors for facial transplantation. Soft-tissue defects (above) and skeletal tissue defects (below).
Figure 3
Figure 3
Some representative changes that can occur in FT patients, especially in those who have faced multiple acute rejection episodes. We noted, especially in patients who faced multiple acute rejection episodes, a lymphedematous aspect, sagging, asymmetry, loss of laxity, and pigmentation changes in the transplanted area.

References

    1. Devauchelle B., Badet L., Lengelé B., Morelon E., Testelin S., Michallet M., D’Hauthuille C., Dubernard J.-M. First human face allograft: Early report. Lancet. 2006;368:203–209. doi: 10.1016/S0140-6736(06)68935-6. - DOI - PubMed
    1. Kantar R.S., Alfonso A.R., Diep G.K., Berman Z.P., Rifkin W.J., Diaz-Siso J.R., Sosin M., Gelb B.E., Ceradini D.J., Rodriguez E.D. Facial Transplantation: Principles and Evolving Concepts. Plast. Reconstr. Surg. 2021;147:1022e–1038e. doi: 10.1097/PRS.0000000000007932. - DOI - PubMed
    1. Diep G.K., Berman Z.P., Alfonso A.R., Ramly E.P., Boczar D., Trilles J., Colon R.R., Chaya B.F., Rodriguez E.D. The 2020 Facial Transplantation Update: A 15-Year Compendium. Plast. Reconstr. Surg. Glob. Open. 2021;9:e3586. doi: 10.1097/GOX.0000000000003586. - DOI - PMC - PubMed
    1. Kantar R.S., Alfonso A.R., Ramly E.P., Diaz-Siso J.R., Jacoby A., Sosin M., Ceradini D.J., Rodriguez E.D. Incidence of Preventable Nonfatal Craniofacial Injuries and Implications for Facial Transplantation. J. Craniofac. Surg. 2019;30:2023–2025. doi: 10.1097/SCS.0000000000005715. - DOI - PubMed
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J. Clin. Epidemiol. 2009;62:1006–1012. doi: 10.1016/j.jclinepi.2009.06.005. - DOI - PubMed

LinkOut - more resources